July 22 Could Ignite a Financial Nightmare

He said “a major reckoning is coming” 3 months before 2025’s crash… his work pointed to the Covid crash 25 days before stocks bottomed… and his firm spends $8 million a year in search of the biggest declines in the stock market. Now – one man has a chilling warning for the financial system on July 22.

Tue, July 22 at 10:00AM ET
 
 
 
 
Register Here

Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

6 Pharmaceutical Stocks to Buy Now

By Portfolio Grader
The grades of six pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

E-Commerce: Facebook (FB) Stock’s Lucrative Hidden Catalyst

By John Divine, InvestorPlace Assistant Editor
Facebook (FB) stock has been crushing the market recently. But, few investors realize the company's potential to become an e-commerce all-star.

Lendingtree Stock Is Growing Like a Weed – Buy TREE ASAP!

By Jeff Reeves
TREE stock posted blowout earnings, and Lendingtree stock is soaring in 2015. Don't delay any longer for a share in this online loans king.

Barrick Gold Is Streamlining to the Top of the Gold Pile

By Craig Adeyanju, InvestorPlace Contributor
It’s a good time for patient investors to get in ABX stock. An investment in Barrick Gold at the moment is a play on streamlined operation.

Liberty Media: Confusing, But With Plenty of Cash Flow

By Lawrence Meyers, InvestorPlace Contributor
You can't beat John Malone for his approach to holding businesses with impressive cash flow. And boy, does he have a lot.

Fitbit (FIT) Stock: This Selloff Is Nonsensical — Buy the Dip!

By John Divine, InvestorPlace Assistant Editor
The Fitbit (FIT) stock price is taking a beating on Thursday, despite a blowout quarterly earnings report. It's a great time to buy FIT on the cheap.

CBS Stock a Good Bet for Cord-Cutting Era

By Larry Ramer, InvestorPlace Contributor
CBS should be able to withstand cord cutting, and CBS stock has multiple catalysts that should push it higher.

GoDaddy Stock: GDDY Is Growing Like a Weed, But …

By Brian Wu, InvestorPlace Contributor
GoDaddy (GDDY) continues to deliver decent top-line growth, but losses and a high expense leave much to be desired in GoDaddy stock.

5 Fashion and Apparel Stocks to Buy Now

By Portfolio Grader
The grades of five fashion and apparel stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

7 Software Stocks to Buy Now

By Portfolio Grader
This week, seven software stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Prime Earnings Surprises — ABMD UBA WRI RDCM BRE

By Portfolio Grader
This week, these five stocks have the best ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

7 Restaurant and Resort Stocks to Buy Now

By Portfolio Grader
Seven restaurant and resort stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

NXP Semiconductors Continues to Deliver (NXPI)

By Louis Navellier, Editor, Growth Investor
NXPI is a major player in the secure mobile space and works with the world's largest companies to make mobile communications secure and reliable.

Zillow Stock Is a Buy Despite Lousy Response to Earnings

By James Brumley, InvestorPlace Feature Writer
Zillow stock may not look like much from a valuation standpoint, but give it time -- it's a story stock, and the story is moving forward for the better.

4 Big Pharma Stocks to Own After Q2 Earnings

By James Brumley, InvestorPlace Feature Writer
Big Pharma has a lot to be proud of following some key second-quarter filings and revised full-year outlooks. Four stocks in particular look buy-worthy.

3 Muscle-Bound Stocks That Will Pull the Bulls Ahead

By Johnson Research Group
We've sorted out 13 relative strength leaders that should carry the Nasdaq forward from here, but three in particular look like market-pulverizing ideas.

5 Stocks to Buy for August

By Dan Burrows, InvestorPlace Feature Writer
Technical strength, strong seasonality and solid fundamentals are hallmarks of these five stocks to buy for outperformance, at least in the short term.

Disney Stock: A Rare Discount Thanks to Earnings (DIS)

By Lior Alkalay, InvestorPlace Contributor
Deep discounts in Disney stock don't come along all that often, so buyers should take advantage of this quick souring on DIS shares.

The Sun Is Shining Bright At First Solar (FSLR)

By Aaron Levitt, InvestorPlace Contributor
First Solar earnings are doing wonders for FSLR stock after its blowout Q2 report. It's a stock to buy despite today's ferocious rally.
Load More Articles